Jakap Koo - 04 Mar 2025 Form 3 Insider Report for Apimeds Pharmaceuticals US, Inc. (APUS)

Role
Director
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
Issuer symbol
APUS
Transactions as of
04 Mar 2025
Net transactions value
$0
Form type
3
Filing time
08 May 2025, 17:31:21 UTC
Next filing
14 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Koo Jakap Director C/O APIMEDS PHARMACEUTICALS US, INC., 2 EAST BROAD STREET, 2ND FLOOR, HOPEWELL /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact 08 May 2025 0002041972

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding APUS Common Stock, par value $0.01 per share 615,385 04 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney